161 related articles for article (PubMed ID: 26990915)
21. [HBsAg carrier state and primary hepatocellular carcinoma--a ten-year prospective study].
Lu JH
Zhonghua Yu Fang Yi Xue Za Zhi; 1988 Sep; 22(5):259-62. PubMed ID: 2853039
[No Abstract] [Full Text] [Related]
22. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.
Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
Gastroenterology; 2012 May; 142(5):1140-1149.e3; quiz e13-4. PubMed ID: 22333950
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma.
Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Batrla-Utermann R; Wang LY; You SL; Hsiao CK; Chen PJ; Chen CJ;
Gut; 2014 Oct; 63(10):1648-57. PubMed ID: 24225939
[TBL] [Abstract][Full Text] [Related]
24. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses.
Wang CS; Yao WJ; Chang TT; Wang ST; Chou P
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2054-60. PubMed ID: 19549812
[TBL] [Abstract][Full Text] [Related]
25. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
26. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
28. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.
Kim GA; Lee HC; Kim MJ; Ha Y; Park EJ; An J; Lee D; Shim JH; Kim KM; Lim YS
J Hepatol; 2015 May; 62(5):1092-9. PubMed ID: 25445399
[TBL] [Abstract][Full Text] [Related]
29. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California.
Yu MC; Yuan JM; Ross RK; Govindarajan S
Hepatology; 1997 Jan; 25(1):226-8. PubMed ID: 8985295
[TBL] [Abstract][Full Text] [Related]
30. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
Grob PJ
Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
[TBL] [Abstract][Full Text] [Related]
31. Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis.
Akuta N; Suzuki F; Kobayashi M; Hara T; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Saitoh S; Ikeda K; Kumada H
J Med Virol; 2014 Jan; 86(1):131-8. PubMed ID: 24123090
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma in hepatitis B surface antigen carriers in eight institutions.
Lohiya GS; Pirkle H; Nguyen H; Lohiya S; Vuu T
West J Med; 1988 Apr; 148(4):426-9. PubMed ID: 2838975
[TBL] [Abstract][Full Text] [Related]
33. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
[TBL] [Abstract][Full Text] [Related]
34. A clinicpathological study of hepatocellular carcinoma in Nagasaki, south-western Japan: the association of hepatitis B and C viruses.
Eto H; Toriyama K; Itakura H
Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):88-92. PubMed ID: 7529945
[TBL] [Abstract][Full Text] [Related]
35. Family history of liver cancer and hepatocellular carcinoma.
Turati F; Edefonti V; Talamini R; Ferraroni M; Malvezzi M; Bravi F; Franceschi S; Montella M; Polesel J; Zucchetto A; La Vecchia C; Negri E; Decarli A
Hepatology; 2012 May; 55(5):1416-25. PubMed ID: 22095619
[TBL] [Abstract][Full Text] [Related]
36. Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma.
Yu MW; Hsieh HH; Pan WH; Yang CS; CHen CJ
Cancer Res; 1995 Mar; 55(6):1301-5. PubMed ID: 7882326
[TBL] [Abstract][Full Text] [Related]
37. What can we learn from hepatitis B virus clinical cohorts?
Lin CL; Tseng TC; Kao JH
Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
[TBL] [Abstract][Full Text] [Related]
38. [A cohort study on the relation of primary liver cancer and HBsAg positivity in Guangxi Province].
Zhang ZQ
Zhonghua Yu Fang Yi Xue Za Zhi; 1989 May; 23(3):141-2. PubMed ID: 2555118
[No Abstract] [Full Text] [Related]
39. Urinary 8-oxodeoxyguanosine, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan.
Wu HC; Wang Q; Wang LW; Yang HI; Ahsan H; Tsai WY; Wang LY; Chen SY; Chen CJ; Santella RM
Carcinogenesis; 2007 May; 28(5):995-9. PubMed ID: 17127712
[TBL] [Abstract][Full Text] [Related]
40. Dietary trace element intake and liver cancer risk: Results from two population-based cohorts in China.
Ma X; Yang Y; Li HL; Zheng W; Gao J; Zhang W; Yang G; Shu XO; Xiang YB
Int J Cancer; 2017 Mar; 140(5):1050-1059. PubMed ID: 27859272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
